Appendix 2: List of witnesses
Evidence is published online at https://committees.parliament.uk/work/7739/homecare-medicines-services/ and available for inspection at the Parliamentary Archives (020 7219 3074).
Evidence received by the Committee is listed below in chronological order of oral evidence session, and then in alphabetical order. Those witnesses marked with ** gave both oral evidence and written evidence. Those marked with * gave oral evidence and did not submit any written evidence. All other witnesses submitted written evidence only.
Oral evidence in chronological order
|
* |
Dr Christian Selinger, Consultant Gastroenterologist and Chair of the Inflammatory Bowel Disease Section, British Society of Gastroenterology |
|
|
** |
Sarah Campbell, Chief Executive, British Society for Rheumatology |
|
|
** |
Ruth Wakeman, Director of Services, Advocacy and Evidence, Crohn’s & Colitis UK |
|
|
** |
Alison Davis, Chair, National Clinical Homecare Association |
|
|
** |
Richard Bateman, Pharmacist and member of the RPS Hospital Expert Advisory Group, Royal Pharmaceutical Society |
|
|
** |
Dr Rick Greville, Director, Distribution & Supply and Association of the British Pharmaceutical Industry Cymru Wales at Association of the British Pharmaceutical Industry |
|
|
** |
Sarah Billington, Deputy Director of Medicines Optimisation, Care Quality Commission |
|
|
** |
Claire Bryce-Smith, Director of Insight, Intelligence & Inspection, General Pharmaceutical Council |
|
|
** |
Joe Bassett, Chair, National Homecare Medicines Committee, and Assistant Director of Procurement, Pharmacy and Healthcare Services, East of England NHS Collaborative Procurement Hub |
|
|
** |
Claire Foreman, Director of Medicines, Policy and Strategy, NHS England |
|
|
** |
David Webb, Chief Pharmaceutical Officer for England, NHS England |
|
|
* |
Will Quince MP, Minister of State (Minister for Health and Secondary Care), Department of Health and Social Care |
|
|
* |
Rahul Singal, Chief Pharmacy & Medicines Information Officer, NHS England |
Alphabetical list of witnesses
|
** |
Joe Bassett, Chair, National Homecare Medicines Committee, and Assistant Director of Procurement, Pharmacy and Healthcare Services, East of England NHS Collaborative Procurement Hub (QQ 38–48) |
|
|
** |
Richard Bateman, Pharmacist and member of the RPS Hospital Expert Advisory Group, Royal Pharmaceutical Society (QQ 16–23) |
|
|
** |
Sarah Billington, Deputy Director of Medicines Optimisation, Care Quality Commission (QQ 24–37) |
|
|
British Association of Dermatologists |
||
|
** |
Claire Bryce-Smith, Director of Insight, Intelligence & Inspection, General Pharmaceutical Council (QQ 24–37) |
|
|
** |
Sarah Campbell, Chief Executive, British Society for Rheumatology (QQ 1–15) |
|
|
Cystic Fibrosis Trust |
||
|
** |
Alison Davis, Chair, National Clinical Homecare Association (QQ 16–23) |
|
|
** |
Claire Foreman, Director of Medicines, Policy and Strategy, NHS England (QQ 38–48) |
|
|
Dr Olivia Goldberg |
||
|
** |
Dr Rick Greville, Director, Distribution & Supply and Association of the British Pharmaceutical Industry Cymru Wales, Association of the British Pharmaceutical Industry (QQ 16–23) |
|
|
Dr Morag Griffin, Leeds Teaching Hospitals NHS Trust |
||
|
Dr Anthony Isaacs MBChB BSc FRCP, Consultant Rheumatologist, Clinical Lead for Rheumatology, London North West Healthcare University Trust and Clinical Chair of the North West London sector Rheumatology CRG |
||
|
Elizabeth Kirsch, Government Affairs Manager Lloyds Pharmacy Clinical Homecare (Part of Hallo Health Group) |
||
|
Parliamentary and Health Services Ombudsman |
||
|
* |
Will Quince MP, Minister of State (Minister for Health and Secondary Care), Department of Health and Social Care (QQ 49–59) |
|
|
Sciensus Pharma Services |
||
|
Sciensus Pharma Services provided private written evidence |
HMS0021 |
|
|
Scottish Government Pharmacy and Medicines Division on Homecare Medicines Services |
||
|
* |
Rahul Singal, Chief Pharmacy & Medicines Information Officer, NHS England (QQ 49–59) |
|
|
Taskforce for Lung Health |
||
|
** |
Ruth Wakeman, Director of Services, Advocacy and Evidence, Crohn’s & Colitis UK (QQ–) |
|
|
** |
David Webb, Chief Pharmaceutical Officer for England, NHS England (QQ 38–48) |
|
|
Phil White |